Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**4-methylumbelliferyl alpha-D-glucopyranoside** is a synthetic small molecule substrate commonly used in biochemical assays to detect and quantify the activity of beta-glucosidase enzymes. Upon enzymatic hydrolysis by beta-glucosidases, it releases the fluorescent compound 4-methylumbelliferone, which can be measured spectroscopically. This compound is not approved as a pharmaceutical drug for therapeutic use but is widely utilized as a research tool in enzymology and diagnostic applications[2][3][5]. It belongs to the class of coumarin glycosides.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-methylumbelliferyl alpha-D-glucopyranoside.